Evaluating wellness programs is a difficult task. There are selection issues, design issues, many confounding variables and other problems. There is little well-designed research either proving or disproving cost savings. Humana issued a report evaluating the effect of its HumanaVitality wellness program. (Humana Report) The study was conducted on 8000 Humana employees using the program since 2011. The program includes pretty typical risk assessment, coaching, educational and other elements and provides an incentive to participate and meet objectives. Employees in the program supposedly had 6% lower health costs in the first year and 10% lower by the third year, compared with people not engaged in the program. Unengaged members had 56% more ER usage and 57% higher hospital visits. People with lifestyle-related chronic conditions showed the greatest decline in costs and usage. In addition, engaged employees had 6 fewer hours of unscheduled absences. Now, this study is an example of why people are so skeptical of wellness program claims. Unless you dig in pretty good, you don’t see that Humana makes up its own definition of “engaged”. Apparently all employees were judged to be in the program, but only some were “engaged”. Obviously there is room for all sorts of confounders here in terms of comparing these populations. A strange form of propensity matching was further used in the comparison. To my somewhat untrained eye, this is a suspect study with suspect conclusions.
Results from Humana Wellness Program
By Kevin RocheApril 12, 2016Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…